Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Regulatory Required Non-interventional Study to Monitor the Safety and Effectiveness of Ofev(Nintedanib 150mg/100mg BID) in Korean Patients

NCT04525547 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT04525547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04525547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Regulatory Required Non-interventional Study to Monitor the Safety and Effectiveness of Ofev(Nintedanib 150mg/100mg BID) in Korean Patients
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
January 13, 2021
Completion date
August 18, 2022
Enrollment
70 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis